AbbVie Submits BLA to FDA for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis Read more
Concert Pharmaceuticals Completes Enrollment in Phase 2a Trial of CTP-543 in Alopecia Areata Read more
Once-daily Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD Read more
PhoenixMD Announces Manufacturing Collaboration with WuXi STA to advance PMD-026 toward IND Read more